1. BIOM-22. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AS A MOLECULAR DETERMINANT OF GLIOBLASTOMA RESPONSE TO DOPAMINE RECEPTOR 2 (DRD2) INHIBITORS. (9th November 2020) Authors: He, Yuyu; Li, Jie; Koga, Tomoyuki; Ma, Jun; Dhawan, Sanjay; Suzuki, Yuta; Furnari, Frank; Prabhu, Varun; Allen, Joshua; Chen, Clark Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BIOM-60. BIOMARKER EVALUATION FOR IMIPRIDONE ONC206 REVEALS ClpP, ATF4, MYC, EGFR and HIF1 AS KEY PREDICTORS OF ANTI-CANCER EFFICACY. (9th November 2020) Authors: Morrow, Sara; Garnett, Mathew; McDermott, Ultan; Benes, Cyril; Allen, Joshua; Prabhu, Varun Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DDIS-20. IMIPRIDONE STRUCTURE ACTIVITY RELATIONSHIP UNCOVERS ONC206 AS THE NEXT BITOPIC DRD2 ANTAGONIST FOR ONCOLOGY WITH DIFFERENTIATED RECEPTOR PHARMACOLOGY. (11th November 2019) Authors: Prabhu, Varun; Cuoco, Caroline; Jung, Jinkyu; Rahman Kawakibi, Abed; Willette, Blair; Day, Marilyn; Anantharaman, Lakshmi; Charter, Neil; Rucker, Joseph; Doranz, Benjamin; Oster, Wolfgang; Stogniew, Martin; Gilbert, Mark; Benjamin Free, R; Sibley, David; Allen, Joshua Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DDRE-33. MOLECULAR DIFFERENTIATION OF IMIPRIDONES ONC201 AND ONC206. (9th November 2020) Authors: Prabhu, Varun; Cuoco, Caroline; Jung, Jinkyu; Morrow, Sara; Kawakibi, Abed Rahman; Willette, Blair; Day, Marilyn; Anantharaman, Lakshmi; Charter, Neil; Rucker, Joseph; Doranz, Benjamin; Basken, Joel; Stogniew, Martin; Gilbert, Mark; Free, R; Sibley, David; Allen, Joshua Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EXTH-33. RECEPTOR PHARMACOLOGY OF ONC201: THE FIRST BITOPIC DRD2 ANTAGONIST FOR CLINICAL NEURO-ONCOLOGY. (11th November 2019) Authors: Benjamin Free, R; Cuoco, Caroline; Prabhu, Varun; Willette, Blair; Day, Marilyn; Anantharaman, Lakshmi; Sulli, Chidananda; Davidson, Edgar; Deacon, Sean; Rucker, Joseph; Charter, Neil; Doranz, Benjamin; Oster, Wolfgang; Stogniew, Martin; Robert Lane, J; Sibley, David; Allen, Joshua Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EXTH-62. PRECLINICAL EFFICACY OF THE IMIPRIDONE ONC-206 AGAINST MEDULLOBLASTOMA. (9th November 2020) Authors: MacDonald, Tobey; Malhotra, Anshu; Liu, Jingbo; Zhang, Hongying; Schneiderjan, Matthew; Vega, Jose Velazquez; Prabhu, Varun; Allen, Joshua Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EXTH-70. CYP450 AND METABOLIC PROFILING OF ANTI-CANCER IMIPRIDONE ONC201. (9th November 2020) Authors: Morrow, Sara; Prabhu, Varun; Tarapore, Rohinton S; Guo, Ailan; Fang, Yunlan; Nej, Magdalena; Stogniew, Martin; Allen, Joshua Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EXTH-71. IND-ENABLING CHARACTERIZATION OF ONC206 AS THE NEXT BITOPIC DRD2 ANTAGONIST FOR NEURO-ONCOLOGY. (11th November 2019) Authors: Prabhu, Varun; Rahman Kawakibi, Abed; Madhukar, Neel; Garnett, Mathew; McDermott, Ultan; Benes, Cyril; Wechsler-Reya, Robert; Elemento, Olivier; Stogniew, Martin; Oster, Wolfgang; DeMorrow, Sharon; Allen, Joshua Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EXTH-74. IND-ENABLING CHARACTERIZATION OF DUAL DRD2- AND ClpP-TARGETING AGENT ONC206 AS THE NEXT IMIPRIDONE FOR CLINICAL NEURO-ONCOLOGY. (9th November 2020) Authors: Prabhu, Varun; Morrow, Sara; Kawakibi, Abed Rahman; Jitkova, Yulia; Jung, Jinkyu; Madhukar, Neel; Garnett, Mathew; McDermott, Ultan; Benes, Cyril; Wechsler-Reya, Robert; Elemento, Olivier; DeMorrow, Sharon; Schimmer, Aaron; Stogniew, Martin; Theeler, Brett; Gilbert, Mark; Allen, Joshua Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. EXTH-77. ONC201 EXHIBITS PASSIVE DIFFUSION AND BROAD DISTRIBUTION IN THE CENTRAL NERVOUS SYSTEM. (9th November 2020) Authors: Morrow, Sara; Prabhu, Varun; Tarapore, Rohinton S; Theerman, Gina; Lake, Leah; Guo, Ailan; Stogniew, Martin; Allen, Joshua Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗